Sangamo Biosciences CEO Alexander Macrae's 2021 pay jumps 23% to $4.7M
Sangamo Biosciences reports 2021 executive compensation
By ExecPay News
Published: April 1, 2022
Sangamo Biosciences reported fiscal year 2021 executive compensation information on April 1, 2022.
In 2021, six executives at Sangamo Biosciences received on average a compensation package of $1.8M, a 10% decrease compared to previous year.
Average pay of disclosed executives at Sangamo Biosciences
Alexander D. Macrae, Chief Executive Officer, received $4.7M in total, which increased by 23% compared to 2020. 43% of Macrae's compensation, or $2M, was in option awards. Macrae also received $446K in non-equity incentive plan, $689K in salary, $1.5M in stock awards, as well as $5.6K in other compensation.
For fiscal year 2021, the median employee pay was $170,218 at Sangamo Biosciences. Therefore, the ratio of Alexander D. Macrae's pay to the median employee pay was 28 to one.
Robert J. Schott, Senior Vice President, Head of Development, received a compensation package of $1.9M. 38% of the compensation package, or $723K, was in option awards.
R. Andrew Ramelmeier, Executive Vice President, Technical Operations, earned $1.7M in 2021, a 10% increase compared to previous year.
D. Mark McClung, Chief Operating Officer, received $1.7M in 2021, which decreases by 38% compared to 2020.
Prathyusha Duraibabu, Chief Financial Officer, earned $1.1M in 2021.
Sung H. Lee, Chief Financial Officer, received $48K in 2021, which decreases by 97% compared to 2020.
Related executives
Alexander Macrae
Sangamo Biosciences
Chief Executive Officer
Prathyusha Duraibabu
Sangamo Biosciences
Chief Financial Officer
D McClung
Sangamo Biosciences
Chief Operating Officer
R Ramelmeier
Sangamo Biosciences
Executive Vice President, Technical Operations
Robert Schott
Sangamo Biosciences
Senior Vice President, Head of Development
Sung Lee
Sangamo Biosciences
Chief Financial Officer
You may also like
Source: SEC filing on April 1, 2022.